Search
Search Results
##search.searchResults.foundPlural##
-
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2638PDF: 1785HTML: 690 -
CLINICAL AND LABORATORY FEATURES OF SICKLE CELL DISEASE S/D PUNJAB: IMPACT OF HBF AND HYDROXYUREA SCD S/D Punjab
1435PDF: 1213HTML: 154 -
SOCIAL IMPLICATIONS OF MALARIA AND THEIR RELATIONSHIPS WITH POVERTY
6314PDF: 3462HTML: 9066Figure Malaria Ricci: 278 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3835PDF: 960HTML: 6883 -
-
ELEVATED P-SELECTIN IN SEVERE COVID-19: CONSIDERATIONS FOR THERAPEUTIC OPTIONS P-Selectine and COVID-19
1995PDF: 780HTML: 254 -
Parasitic hypereosinophilia in childhood: a diagnostic challenge
2711PDF: 871HTML: 384Figure 1: 216 -
THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
4190PDF: 1225HTML: 2116Fig.1: 241Fig. 2: 132Table 1: 244Table2: 262Table 3: 237 -
Lymphomatoid Granulomatosis of Central Nervous System and Lung Driven by Epstein Barr Virus Proliferation: Successful Treatment with Rituximab
1719PDF: 961HTML: 3197Figure 5: 191Figure 4: 191Figure 3: 225Figure 1: 206Figure 2: 204 -
OUTLINE OF IRON METABOLISM, WITH EMPHASIS TO ERYTHROID CELLS iron Metabolism
2465PDF: 1359Html: 1056 -
CAR-T CELL THERAPY FOR T-CELL MALIGNANCIES CAR-T CELL FOR T-CELL MALIGNANCIES
2405PDF: 2142HTML: 232 -
THE PROGNOSTIC SIGNIFICANCE OF TET2 SINGLE NUCLEOTIDE POLYMORPHISM IN EGYPTIAN CHRONIC MYELOID LEUKEMIA THE PROGNOSTIC SIGNIFICANCE OF TET2 SINGLE NUCLEOTIDE POLYMORPHISM IN EGYPTIAN CHRONIC MYELOID LEUKEMIA
2190PDF: 1038HTML: 336 -
TYROSINE KINASE INHIBITORS AND INTERFERON
2997PDF: 1501HTML: 3102Cover Letter: 251 -
FUNGAL INFECTIONS OF THE EAR IN IMMUNOCOMPROMISED HOST: A REVIEW
3906PDF: 1597HTML: 3887Letter to Editor: 230 -
ACUTE LUNG INJURY COMPLICATING BLOOD TRANSFUSION IN POST-PARTUM HEMORRHAGE: INCIDENCE AND RISK FACTORS.
2586PDF: 1327HTML: 3625Acute lung injury complicating blood transfusion in post-partum hemorrhage: incidence and risk factors.: 454 -
TARGETING DORMANT BACILLI TO FIGHT TUBERCULOSIS
3196PDF: 1073HTML: 3225 -
HEMATOLOGICAL ABNORMALITIES BEYOND LYMPHOCYTOSIS DURING INFECTIOUS MONONUCLEOSIS: EPSTEIN-BARR VIRUS-INDUCED THROMBOCYTOPENIA THROMBOCYTOPENIA DURING INFECTIOUS MONONUCLEOSIS
2362HTML: 671PDF: 1418 -
ASSOCIATION OF VDBP RS4701 VARIANT, BUT NOT VDR/RXR-? OVER-EXPRESSION WITH BONE MINERAL DENSITY IN PEDIATRIC ?-THALASSEMIA PATIENTS Vitamin D metabolic axis and BMD in ?-thalassemia
1383PDF: 784HTML: 293 -
DETECTION OF ANTINUCLEAR ANTIBODIES TARGETING INTRACELLULAR SIGNAL TRANSDUCTION, METABOLISM, APOPTOTIC PROCESSES AND CELL DEATH IN CRITICAL COVID-19 PATIENTS
1580PDF: 1130HTML: 443Suppl. Figure: 217Suppl. Tables: 237 -
DISTRIBUTION OF DNA DAMAGE REPAIR GENE POLYMORPHISM hOGG1, XRCC1 and p53 AMONG SICKLE CELL DISEASE PATIENTS IN INDIA
1647PDF: 835HTML: 1538Table Genotype and allele frequencies of hOGG1 codon 326 Ser>Cys and p53 72Arg>Pro polymorphisms among SCD patients and control group: 216 -
APPROACHING THE TARGET: THE PATH TOWARDS AN EFFECTIVE MALARIA VACCINE
2717PDF: 1028HTML: 15139 -
HISTORY OF ACUTE PROMYELOCYTIC LEUKEMIA: A TALE OF ENDLESS REVOLUTION
3313PDF: 1166HTML: 1960 -
-
Diagnosis of del(5q) MDS, 14 years after JAK-2 positive PV appearance: complete remission of both diseases with lenalidomide monotherapy
2940PDF: 812HTML: 1312Blood Count trend before and during lenalidomide treatment: 225Light micrograph of bone marrow biopsy of a patient with PV and 5q deletion: 230 -
MANAGEMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN THE ELDERLY
2879PDF: 1225HTML: 3319







